DEA Puts Narcolepsy Pill Orzeyful in Schedule IV as Takeda Launches It in U.S. at $16,500 per Bottle
Takeda launched Orzeyful in the United States at a list price of $16,500 per 60-tablet bottle after the DEA classified its active ingredient as a Schedule IV drug.
Medical Daily ·